Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Luspatercept for Treating Anemia in Patients with Myelodysplastic Syndromes or Myeloproliferative Neoplasms

Trial Status: active

This phase II trial tests how well luspatercept works in treating anemia in patients with myelodysplastic syndromes or myeloproliferative neoplasms. Luspatercept is a drug that increases differentiation and proliferation of blood-forming cells. It works to enhance red blood cell production and prevent anemia.